Sep 10, 2019
Studies confirm strong analytical performance for body fluid and pathological sample analysis of HELO platform
Jul 26, 2019
Specific, intermediate glycemic control marker for diabetes at EKF’s Booth #2952 at AACC 2019 Clinical Lab Expo – 6-8th August 2019
Jul 16, 2019
POC HbA1c study at Great Western Hospitals NHS Foundation Trust is finalist for
2019 RCOphth/Bausch+Lomb Sustainability Prize
Jun 17, 2019
Oxford, UK – 13 June 2019. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq™ portfolio with a complete library preparation solution for hybridisation-based target capture in NGS, making its market-leading coverage uniformity and expertise even more accessible.
May 28, 2019
Northampton, UK – 28th May 2019 – HORIBA UK Ltd, Medical announces the go live of the first multi-site installation of its new HELO high throughput fully automated haematology platform within the Cardiff and Vale University Health Board. The new system is already delivering laboratory efficiencies across Cardiff in line with NHS requirements through the next generation haematology analysers installed at the University Hospital of Wales (UHW) and University Hospital, Llandough. Both sites are f...
May 20, 2019
Seralite®– FLC Serum granted registration by the Brazilian Health Regulatory Agency (ANVISA)
Abingdon Health is pleased to announce Seralite® – FLC Serum has been granted registration by the Brazilian Health Regulatory Agency (ANVISA)
Mar 29, 2019
The Leiden based biotechnology firm Idris Oncology is one of the three SME’s in Europe to receive human tissue through the Codex4SME’s consortium, in order to help them progress their diagnostic product towards clinical application.
Mar 27, 2019
New Yumizen GDDi 2 (D-Dimer) reagent kit for DVT and Pulmonary Embolism diagnosis
Mar 13, 2019
Study to show high accuracy of SNPfitR in predicting Alzheimer’s risk in both carriers and non-carriers of ApoE4
Feb 07, 2019
Crawley, UK – 07 February 2019 – Radiometer Limited’s AQT90 FLEX analysers have been used in a successful trial to asses D-dimer point-of-care testing (POCT) for suspected lower limb deep vein thrombosis (DVT). The editorial piece, published in Emergency Nurse , describes a reduction in patient waiting times of up to 75%.